Biotech | May 23, 2022
Soligenix receives US patent allowance for its thermostabilized vaccine platform
Includes thermostabilized Ebola vaccines
Includes thermostabilized Ebola vaccines
Phase I trial in Rwanda and South Africa aims to evaluate mRNA HIV vaccine antigen for safety and immunogenicity and strengthen regional scientific capacity
Adynovate in combination with Mypkfit offers personalized treatment and enables HCPs and patients to monitor factor levels from home and help achieve optimum QOL outcomes
The move comes a few weeks after receiving the EUA for children between the ages of 5 and 12
Biocon Biologics’ Insugen formulations will be available to patients at all Ministry of Health hospitals, district health offices and health clinics
This is the first major brand refresh of CanSinoBIO since its inception in 2009
Continuation of pediatric expansion in adolescents of PREVENT-19 Phase 3 trial will evaluate safety and immunogenicity of a booster dose
Approval for primary and booster immunization is based on efficacy and safety data from Japan and international clinical studies
The facility will support clinical development by securing supply that will address the critical demand in the gene therapy and vaccine markets
This marks an expansion of the companies' existing collaboration and further validates the use of Albumedix Recombumin rHA products in the manufacturing process and final formulation of critical vaccines
Subscribe To Our Newsletter & Stay Updated
